investorscraft@gmail.com

Intrinsic Value of Encompass Health Corporation (EHC)

Previous Close$119.04
Intrinsic Value
Upside potential
Previous Close
$119.04

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Encompass Health Corporation operates as a leading provider of post-acute healthcare services in the U.S., specializing in inpatient rehabilitation and home health services. The company generates revenue primarily through patient care reimbursements from Medicare, Medicaid, and private insurers, leveraging its network of over 150 hospitals and home health agencies. Its vertically integrated model ensures continuity of care, positioning it as a critical player in the post-acute care continuum. Encompass Health differentiates itself through clinical excellence, evidenced by high patient satisfaction scores and industry-leading outcomes. The company benefits from favorable demographic trends, including an aging population and increasing demand for rehabilitation services. Its scale and operational efficiency provide a competitive edge in negotiating payer contracts and optimizing care delivery. The post-acute sector remains fragmented, allowing Encompass Health to capitalize on consolidation opportunities while maintaining a strong market position in key regions.

Revenue Profitability And Efficiency

Encompass Health reported $5.37 billion in revenue for FY 2024, with net income of $455.7 million, reflecting a net margin of approximately 8.5%. The company’s operating cash flow of $1.0 billion underscores its ability to convert earnings into cash efficiently. Capital expenditures of $642.5 million indicate ongoing investments in facility upgrades and expansion, supporting long-term growth. Diluted EPS of $4.46 demonstrates solid profitability per share.

Earnings Power And Capital Efficiency

The company’s earnings power is driven by its high-margin rehabilitation services and disciplined cost management. Operating cash flow coverage of capital expenditures suggests sustainable reinvestment capacity. With a focus on optimizing bed utilization and payer mix, Encompass Health maintains strong returns on invested capital, though its leverage ratio warrants monitoring given $2.71 billion in total debt.

Balance Sheet And Financial Health

Encompass Health’s balance sheet shows $85.4 million in cash and equivalents against $2.71 billion in total debt, indicating moderate liquidity. The debt load is manageable given stable cash flows, but refinancing risks may arise in higher-rate environments. The company’s asset-light model in home health services helps maintain financial flexibility, though inpatient rehabilitation requires significant fixed investments.

Growth Trends And Dividend Policy

Growth is supported by demographic tailwinds and strategic acquisitions, with revenue expanding steadily year-over-year. The company pays a dividend of $0.63 per share, offering a modest yield, reflecting a balanced approach to returning capital while funding expansion. Same-store admissions and pricing power remain key drivers of organic growth.

Valuation And Market Expectations

The market values Encompass Health at a premium relative to peers, reflecting its leadership in post-acute care and consistent execution. Investors likely price in mid-single-digit revenue growth and margin stability, though regulatory changes in reimbursement rates could impact valuations. The stock’s performance hinges on volume recovery and cost containment in a labor-sensitive industry.

Strategic Advantages And Outlook

Encompass Health’s integrated care model and scale provide durable advantages in a fragmented market. Near-term challenges include labor cost inflation and regulatory scrutiny, but long-term demand for rehabilitation services remains robust. Strategic investments in technology and outpatient care could further diversify revenue streams. The outlook is positive, assuming execution on operational efficiencies and disciplined M&A.

Sources

10-K filings, investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount